TLDR Fluridil promotes hair growth safely and effectively for androgenetic alopecia.
The paper discusses the development of fluridil, a topical suppressor of the androgen receptor for the treatment of androgenetic alopecia (AGA). Fluridil was found to be effective in promoting hair growth in a 12-month clinical study of male AGA patients, with no adverse side effects reported. The compound was designed to achieve rapid degradation into innocuous components, no systemic absorption from the scalp, and topical delivery to the dermal hair papilla. Fluridil was shown to be well-tolerated and safe in mice, with little potential for human hazard at the intended topical dose. The study suggests that fluridil may be a promising treatment for AGA.View this study on onlinelibrary.wiley.com →
Minoxidil and finasteride treat hair loss; more research needed for other options.
Topical finasteride doesn't reduce DHT levels, hinting at an endocrine role in hair loss.
Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.
Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.
RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.
Testosterone can slow down hair growth when combined with certain cells from bald scalps, and this effect can be blocked by an androgen receptor blocker.
Topical finasteride helps regrow hair and reduce balding without side effects.
Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.
RU 58841 may treat acne, hair loss, and excessive hair growth.